
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>NICE CKS: HIV Infection & AIDS - Clinical Guidance</title>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300;400;500;700&display=swap" rel="stylesheet">
  <style>
    * {
      margin: 0;
      padding: 0;
      box-sizing: border-box;
    }

    body {
      font-family: 'Roboto', sans-serif;
      background-color: #f8f9fa;
      color: #333;
      line-height: 1.6;
    }

    .container {
      max-width: 1000px;
      margin: 30px auto;
      padding: 20px;
      background: white;
      border-radius: 12px;
      box-shadow: 0 6px 20px rgba(0, 0, 0, 0.1);
    }

    header {
      text-align: center;
      margin-bottom: 30px;
      padding-bottom: 20px;
      border-bottom: 1px solid #eaeaea;
    }

    header h1 {
      font-size: 28px;
      font-weight: 700;
      color: #1a539d;
    }

    header p {
      font-size: 16px;
      color: #555;
      margin-top: 8px;
    }

    .revision {
      font-size: 14px;
      color: #777;
      font-style: italic;
    }

    .section {
      margin-bottom: 30px;
      padding: 20px;
      background: #f5f9ff;
      border-left: 5px solid #1a539d;
      border-radius: 8px;
    }

    .section h2 {
      font-size: 20px;
      color: #1a539d;
      margin-bottom: 15px;
      font-weight: 500;
    }

    .section ul {
      list-style-type: none;
      padding-left: 10px;
    }

    .section ul li {
      margin-bottom: 10px;
      padding-left: 20px;
      position: relative;
    }

    .section ul li::before {
      content: "•";
      color: #1a539d;
      font-weight: bold;
      position: absolute;
      left: 0;
    }

    .card-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
      gap: 20px;
      margin-top: 20px;
    }

    .card {
      background: white;
      padding: 18px;
      border-radius: 10px;
      box-shadow: 0 4px 10px rgba(0, 0, 0, 0.05);
      border: 1px solid #e0e7ff;
    }

    .card h3 {
      font-size: 18px;
      color: #1a539d;
      margin-bottom: 12px;
      font-weight: 500;
    }

    .card ul {
      list-style: none;
    }

    .card ul li::before {
      content: "→";
      color: #1a539d;
      margin-right: 8px;
    }

    .highlight-box {
      background: #e8f4fc;
      padding: 16px;
      border-radius: 8px;
      border-left: 5px solid #007acc;
      margin: 20px 0;
      font-size: 15px;
    }

    .footer {
      text-align: center;
      margin-top: 40px;
      font-size: 13px;
      color: #888;
      padding-top: 20px;
      border-top: 1px solid #eee;
    }

    .footer p {
      margin: 5px 0;
    }
  </style>
</head>
<body>
  <div class="container">
    <header>
      <h1>HIV Infection and AIDS: Clinical Guidance</h1>
      <p>Condensed reference for healthcare professionals based on NICE CKS</p>
      <p class="revision">Last revised: March 2025</p>
    </header>

    <div class="section">
      <h2>When to Suspect HIV</h2>
      <ul>
        <li>Persistent generalized lymphadenopathy</li>
        <li>Unexplained weight loss, fever, night sweats, or diarrhea</li>
        <li>Recurrent infections (e.g., shingles, oral thrush, bacterial pneumonia)</li>
        <li>Opportunistic infections or AIDS-defining conditions</li>
        <li>Sexual health concerns, STIs, or high-risk sexual behavior</li>
        <li>History of injecting drug use, incarceration, or migration from high-prevalence country (>1% adult HIV prevalence)</li>
        <li>Pregnancy (routine offer of testing)</li>
        <li>Partner known to be HIV-positive</li>
      </ul>
    </div>

    <div class="section">
      <h2>Diagnosis</h2>
      <ul>
        <li><strong>Test:</strong> 4th generation HIV p24 antigen/antibody combination immunoassay (blood)</li>
        <li>Rapid point-of-care tests acceptable if followed by lab confirmation</li>
        <li><strong>Reactive test → Confirm</strong> with differentiation assay (HIV-1/2) and viral load/CD4</li>
        <li><strong>Diagnosis confirmed</strong> by positive immunoassay + differentiation assay or positive virological test (e.g., RNA PCR)</li>
      </ul>
    </div>

    <div class="section">
      <h2>Immediate Actions After Diagnosis</h2>
      <ul>
        <li>Refer urgently (within 7 days) to specialist HIV service</li>
        <li>Discuss transmission risks, prevention, partner notification, mental health, and ART adherence</li>
        <li>Do not initiate ART in primary care — manage by specialists</li>
      </ul>
    </div>

    <div class="section">
      <h2>Screening Recommendations</h2>
      <p>Offer opt-out HIV testing to:</p>
      <ul>
        <li>All patients in high-prevalence areas (diagnosis rate >2/1000)</li>
        <li>Pregnant women (routine antenatal screening)</li>
        <li>Anyone with HIV risk factor(s)</li>
        <li>Individuals attending sexual health, drug services, or TB clinics</li>
      </ul>
      <p>Repeat testing annually in ongoing risk.</p>
    </div>

    <div class="section">
      <h2>Acute HIV (Seropositive Illness)</h2>
      <ul>
        <li>Suspect in flu-like illness (fever, rash, pharyngitis, myalgia) 2–6 weeks post-exposure</li>
        <li>If high suspicion but negative/indeterminate test → test HIV RNA (PCR)</li>
        <li>Urgent referral — early ART may improve outcomes</li>
      </ul>
    </div>

    <div class="section">
      <h2>Referral & Admission Criteria</h2>
      <div class="card-grid">
        <div class="card">
          <h3>Refer Urgently (within 7 days)</h3>
          <ul>
            <li>Suspected acute HIV with symptoms</li>
            <li>Opportunistic infections (e.g., PCP, toxoplasmosis)</li>
            <li>CD4 < 200 cells/µL</li>
            <li>AIDS-defining illness (e.g., Kaposi’s sarcoma)</li>
            <li>ART toxicity or failure</li>
          </ul>
        </div>
        <div class="card">
          <h3>Admit Immediately</h3>
          <ul>
            <li>Hemodynamic instability</li>
            <li>Severe infection (e.g., PJP pneumonia, sepsis)</li>
            <li>Neurological compromise</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="section">
      <h2>Post-Exposure Prophylaxis (PEP)</h2>
      <ul>
        <li>Consider PEP if: recent (≤72 hrs) high-risk exposure (e.g., condomless sex with HIV+ partner, needle-stick)</li>
        <li>Start PEP within 72 hours (sooner = better)</li>
        <li>Typical regimen: tenofovir/emtricitabine + dolutegravir for 28 days</li>
        <li>Refer to sexual health or A&E for assessment and initiation</li>
      </ul>
      <div class="highlight-box">
        <strong>Note:</strong> PEP not needed after exposure to an HIV-positive partner with sustained undetectable viral load.
      </div>
    </div>

    <div class="section">
      <h2>Long-Term Management in Primary Care</h2>
      <ul>
        <li>Monitor for cardiovascular, renal, hepatic, and bone disease</li>
        <li>Vaccinations: annual flu, pneumococcal, HPV, hepatitis A/B</li>
        <li>Screen for depression, anxiety, and substance use</li>
        <li>Support sexual & reproductive health (including safe conception)</li>
        <li>Lifestyle advice: smoking cessation, alcohol, diet, exercise</li>
        <li>Coordinate with specialist HIV team — shared care encouraged</li>
      </ul>
    </div>

    <div class="section">
      <h2>Key Clinical Messages</h2>
      <div class="highlight-box">
        <ul>
          <li><strong>Early diagnosis saves lives</strong> — maintain a low threshold for testing.</li>
          <li><strong>All diagnosed cases require urgent specialist referral.</strong></li>
          <li><strong>PEP must start ≤72 hours post-exposure.</strong></li>
          <li><strong>Undetectable = Untransmittable (U=U)</strong> — reinforce with patients.</li>
          <li><strong>No cure, but ART enables near-normal life expectancy.</strong></li>
        </ul>
      </div>
    </div>

    <div class="footer">
      <p>Based on NICE CKS – HIV Infection and AIDS (March 2025)</p>
      <p>© Clarity Informatics Ltd (trading as Agilio Software Primary Care). Used under licence from NICE.</p>
      <p>For full guidance, visit <a href="https://cks.nice.org.uk" style="color: #1a539d;">cks.nice.org.uk</a></p>
    </div>
  </div>
</body>
</html>
